Journal
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Volume 22, Issue 2, Pages 351-366Publisher
SPRINGER
DOI: 10.1007/s11154-020-09621-1
Keywords
Lean; Non-alcoholic fatty liver disease; Nonalcoholic Steatohepatitis; Nonobese; Nonoverweight; Metabolic syndrome
Categories
Ask authors/readers for more resources
NAFLD is not only associated with obesity but can also occur in individuals with normal body weight. Research on Lean NAFLD helps to better understand the risk factors, disease progression, and potential treatments for this condition.
Classically, Non-Alcoholic Fatty Liver Disease (NAFLD) has been thought to be driven by excessive weight gain and obesity. The overall greater awareness of this disorder has led to its recognition in patients with normal body mass index (BMI). Ongoing research has helped to better understand potential causes of Lean NAFLD, the risks for more advanced disease, and potential therapies. Here we review the recent literature on prevalence, risk factors, severity of disease, and potential therapeutic interventions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available